Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
NCT ID: NCT06364748
Last Updated: 2025-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2024-03-11
2025-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telematics Device for Daily Monitoring of Vital Signs in Cancer
NCT05650814
Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care
NCT00300261
Hypertension Management Using Remote Patient Monitoring: Study 2
NCT04764318
Help Veterans Experience Less Pain Study (HELP-Vets)
NCT00230932
Comparative in Patient, Non-intervention Study of the Remote Physiological Monitoring System (RPM™) vs Standard Physiological Monitoring Devices
NCT00664924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smart Cuff Group
Smart blood pressure cuff
Cellular enabled blood pressure cuff
Smart cuff
Control Group
Standard of care
Standard of Care Cuff
Standard blood pressure cuff
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cellular enabled blood pressure cuff
Smart cuff
Standard of Care Cuff
Standard blood pressure cuff
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Participant is a current patient at West Michigan Cancer Center/Bronson Cancer Center.
3. Participant is receiving bevacizumab as part of active treatment.
4. Participant is willing and able to provide written informed consent.
Exclusion Criteria
2. Participant is hospitalized.
3. Participants are unable to obtain blood pressure readings at home.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Veta Health
UNKNOWN
West Michigan Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Shalowitz
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Shalowitz
Role: PRINCIPAL_INVESTIGATOR
West Michigan Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Michigan Cancer Center
Kalamazoo, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002-2024-Shalowitz
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.